184 related articles for article (PubMed ID: 21449008)
1. Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
Gallagher CL; Oakes TR; Johnson SC; Chung MK; Holden JE; Bendlin BB; McLaren DG; Xu G; Nickles RJ; Pyzalski R; DeJesus O; Brown WD
Mov Disord; 2011 Mar; 26(4):614-20. PubMed ID: 21449008
[TBL] [Abstract][Full Text] [Related]
2. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
[TBL] [Abstract][Full Text] [Related]
3. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
4. A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
Li CT; Palotti M; Holden JE; Oh J; Okonkwo O; Christian BT; Bendlin BB; Buyan-Dent L; Harding SJ; Stone CK; DeJesus OT; Nickles RJ; Gallagher CL
Synapse; 2014 Aug; 68(8):325-31. PubMed ID: 24710997
[TBL] [Abstract][Full Text] [Related]
5. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
[TBL] [Abstract][Full Text] [Related]
6. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
7. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
[TBL] [Abstract][Full Text] [Related]
8. Contralateral Posterior Putaminal
Zhou LL; Wang SY; Tian YY; Jiang T; Chen YC; Huang T; Zhang YD; Wang F
Curr Neurovasc Res; 2021; 18(4):465-469. PubMed ID: 34809545
[TBL] [Abstract][Full Text] [Related]
9. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
[TBL] [Abstract][Full Text] [Related]
10. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopa and glucose metabolism in PD patients with freezing of gait.
Bartels AL; de Jong BM; Giladi N; Schaafsma JD; Maguire RP; Veenma L; Pruim J; Balash Y; Youdim MB; Leenders KL
Mov Disord; 2006 Sep; 21(9):1326-32. PubMed ID: 16721756
[TBL] [Abstract][Full Text] [Related]
13. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Gallagher CL; Johnson SC; Bendlin BB; Chung MK; Holden JE; Oakes TR; Brooks BR; Konopacki RA; Dogan S; Abbs JH; Xu G; Nickles RJ; Pyzalski RW; Dejesus OT; Brown WD
Brain Imaging Behav; 2011 Sep; 5(3):203-11. PubMed ID: 21556744
[TBL] [Abstract][Full Text] [Related]
15. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
Hilker R; Schweitzer K; Coburger S; Ghaemi M; Weisenbach S; Jacobs AH; Rudolf J; Herholz K; Heiss WD
Arch Neurol; 2005 Mar; 62(3):378-82. PubMed ID: 15767502
[TBL] [Abstract][Full Text] [Related]
17. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
18. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
Nurmi E; Ruottinen HM; Bergman J; Haaparanta M; Solin O; Sonninen P; Rinne JO
Mov Disord; 2001 Jul; 16(4):608-15. PubMed ID: 11481683
[TBL] [Abstract][Full Text] [Related]
19. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
[TBL] [Abstract][Full Text] [Related]
20. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
